Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Maris

Showing results (11-20 of 401) with videos related to

Pageof 41
Sort By:
Cancer Cell|February 21, 2012
PI3King on MYCN to improve neuroblastoma therapeuticsMichael D Hogarty, John M Maris
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Identifying rare events in rare diseasesEdward F Attiyeh, John M Maris
Cancer|November 6, 2015
Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterationsKristopher R Bosse, John M Maris
Pediatric Research|November 6, 2022
Dr Audrey E. Evans (1925-2022): academic trailblazer par excellenceMax J Coppes, John M Maris
Molecular Oncology|December 14, 2020
Refining immunotherapeutic approaches to high-risk neuroblastoma based on tumor genomic profilesLiron D Grossmann, John M Maris
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2012
New strategies in refractory and recurrent neuroblastoma: translational opportunities to impact patient outcomeKristina A Cole, John M Maris
Pediatric Blood & Cancer|June 19, 2014
The promises and pitfalls of genetic epidemiologic approaches to pediatric cancers: lessons from MDM2Lee D McDaniel, John M Maris
Nature Reviews. Cancer|February 18, 2015
Revisiting tissue specificity of germline cancer predisposing mutationsJohn M Maris, Alfred G Knudson
Cancer Cell|December 25, 2002
Focus on embryonal malignanciesJohn M Maris, Christopher T Denny
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Inhibition of ALK signaling for cancer therapyYael P Mossé, Andrew Wood, John M Maris
Pageof 41

Showing results (11-20 of 401) with videos related to

Sort By:
Pageof 41
Cancer Cell|February 21, 2012
PI3King on MYCN to improve neuroblastoma therapeuticsMichael D Hogarty, John M Maris
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Identifying rare events in rare diseasesEdward F Attiyeh, John M Maris
Cancer|November 6, 2015
Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterationsKristopher R Bosse, John M Maris
Pediatric Research|November 6, 2022
Dr Audrey E. Evans (1925-2022): academic trailblazer par excellenceMax J Coppes, John M Maris
Molecular Oncology|December 14, 2020
Refining immunotherapeutic approaches to high-risk neuroblastoma based on tumor genomic profilesLiron D Grossmann, John M Maris
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2012
New strategies in refractory and recurrent neuroblastoma: translational opportunities to impact patient outcomeKristina A Cole, John M Maris
Pediatric Blood & Cancer|June 19, 2014
The promises and pitfalls of genetic epidemiologic approaches to pediatric cancers: lessons from MDM2Lee D McDaniel, John M Maris
Nature Reviews. Cancer|February 18, 2015
Revisiting tissue specificity of germline cancer predisposing mutationsJohn M Maris, Alfred G Knudson
Cancer Cell|December 25, 2002
Focus on embryonal malignanciesJohn M Maris, Christopher T Denny
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Inhibition of ALK signaling for cancer therapyYael P Mossé, Andrew Wood, John M Maris
Pageof 41